Grace Therapeutics, Inc.

GRCE·NASDAQ·$2.36Share Price as of 11/2·$37MMarket Cap as of 11/2

Financials

10-QQ1 ended 06/30/2608/13/26 10-KFY 202606/18/26 10-QQ3 ended 12/31/2502/12/26 10-Q/AQ2 ended 09/30/2511/17/25 10-QQ2 ended 09/30/2511/13/25

Disclosures

8-KCurrent report09/18/26 8-KCurrent report08/13/26 8-KCurrent report08/06/26 8-KCurrent report07/28/26 8-KCurrent report06/18/26

Prospectuses and Registrations

S-3Shelf registration08/24/26 S-3Shelf registration03/10/25 POS AMPost-effective amendment10/08/24 POS AMPost-effective amendment10/08/24 S-8Registration of securities for employees10/08/24

Proxies

DEF 14ADefinitive proxy07/28/26 DEFA14AAdditional proxy materials07/28/26 DEF 14ADefinitive proxy07/28/25 DEFA14AAdditional proxy materials07/28/25 DEFA14AAdditional proxy materials09/06/24

Ownership

Form 4Insider transaction10/26/26 Form 4Insider transaction10/21/26 Form 4Insider transaction10/16/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/05/26

Other

EFFECTRequest for effectiveness08/31/26 DD08/11/26 EFFECTRequest for effectiveness03/13/25 CORRESPCorrespondence with the SEC03/12/25 UPLOADLetter from the SEC03/11/25